Signe Holm Nielsen
Signe Holm Nielsen publishes mostly in Rheumatology, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine, on topics such as Spondyloarthritis Studies and Treatments, Rheumatoid Arthritis Research and Therapies and Protease and Inhibitor Mechanisms.
- World rank
- #2,061,902 of 7,710,434 ranked researchers
- Rank in Denmark
- #15,547 of 43,819
- Works
- 162
- Citations
- 2.4k
- Citations per work
- 14.8
What does Signe Holm Nielsen research?
Signe Holm Nielsen's work is mostly in Medicine (37%), Biochemistry, Genetics and Molecular Biology (6%), Immunology and Microbiology (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else8250.8%
- Health Sciences6036.9%
- Medicine6036.9%
- Life Sciences2012.3%
- 1Rheumatology15% of their works
- 2Cardiology and Cardiovascular Medicine9% of their works
- 3Pulmonary and Respiratory Medicine6% of their works
- 4Pathology and Forensic Medicine6% of their works
- 5Molecular Biology6% of their works
- 6Immunology6% of their works
Research topics
- Spondyloarthritis Studies and Treatments
- Rheumatoid Arthritis Research and Therapies
- Protease and Inhibitor Mechanisms
- Cell Adhesion Molecules Research
- Cardiac Fibrosis and Remodeling
- Systemic Sclerosis and Related Diseases
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Psoriasis: Treatment and Pathogenesis
Which keywords describe Signe Holm Nielsen's research?
The keywords of their largest research topics: Extracellular Matrix, Fibrosis, Inflammation, Cytokines, Angiogenesis, Autoantibodies, TGF-ß and Ankylosing Spondylitis.
- IL-17
- Pulmonary Involvement
- Idiopathic Pulmonary Fibrosis
- Cardiac Remodeling
- Matrix Metalloproteinases
- Cell Adhesion
- Biological Therapy
- Ankylosing Spondylitis
- Autoantibodies
- Cytokines
- Fibrosis
- Extracellular Matrix
- Inflammation
- Angiogenesis
- TGF-ß
- Spondyloarthritis
- Rheumatoid Arthritis
- Integrins
- Tissue Inhibitors of Metalloproteinases
- Inflammatory Response
- Interstitial Lung Disease
- Systemic Sclerosis
- TH17 Cells
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 23 words, with their numbers
- Extracellular Matrix523 topics
- Fibrosis423 topics
- Inflammation412 topics
- Cytokines392 topics
- Angiogenesis362 topics
- Autoantibodies362 topics
- TGF-ß252 topics
- Ankylosing Spondylitis241 topic
- Spondyloarthritis241 topic
- Biological Therapy231 topic
- Rheumatoid Arthritis231 topic
- Cell Adhesion181 topic
- Integrins181 topic
- Matrix Metalloproteinases181 topic
- Tissue Inhibitors of Metalloproteinases181 topic
- Cardiac Remodeling161 topic
- Inflammatory Response161 topic
- Idiopathic Pulmonary Fibrosis131 topic
- Interstitial Lung Disease131 topic
- Pulmonary Involvement131 topic
- Systemic Sclerosis131 topic
- IL-17121 topic
- TH17 Cells121 topic
Where does Signe Holm Nielsen work?
Signe Holm Nielsen's main affiliation in the publication record is Nordic Bioscience (Denmark), Denmark.
How many publications and citations does Signe Holm Nielsen have?
OpenAlex counts 162 works and 2,402 citations for Signe Holm Nielsen, an h-index of 26, ranking #2,061,902 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Signe Holm Nielsen. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.